Case scenario

Charlie, a 54-year-old regular patient of your pharmacy, comes in with a prescription for varenicline. He discloses that his smoking has increased significantly since his divorce and that it escalated further during the isolation periods of the COVID-19 pandemic. His other medicines include amlodipine, atorvastatin and fluoxetine. You dispense the varenicline and ask that he join you in the private consulting room to have a chat about his new medicine. 

Introduction

Despite being the most technologically connected society in history, we appear to be the loneliest. Robust scientific evidence has declared loneliness a significant danger to the health of the individual and the public health system.1

Internationally, countries are recognising its significance. In 2018, London appointed a minister of loneliness and adopted a national loneliness strategy,2 and in 2021 Japan also appointed a minister of loneliness.1 The World Health Organization (WHO) has shared plans for the establishment of a global commission to address loneliness, including the development of a global index on social connection to help measure social connection around the world and allow progress of interventions to be tracked.3 Most recently (May 2023) the US Surgeon General, Dr Vivek Murthy, released an Advisory addressing loneliness and isolation, and laid out a framework for a National Strategy to Advance Social Connection.41 However,  loneliness h

THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.